COCP: Cocrystal Pharma, Inc. Stock

by  •  • Comments Off on COCP: Cocrystal Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 19.84
Enterprise Value ($M) -2.00
Book Value ($M) 22.59
Book Value / Share 2.22
Price / Book 0.88
NCAV ($M) 20.53
NCAV / Share 2.02
Price / NCAV 0.97

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -0.44
Return on Equity (ROE) -0.48

Liquidity (mrq)
Quick Ratio 10.30
Current Ratio 10.30

Balance Sheet (mrq) ($M)
Current Assets 24.49
Assets 26.55
Liabilities 3.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -21.16
Net Income -17.98
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Beore Dividends Basic n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -14.67
Cash from Investing -0.12
Cash from Financing 3.99

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-02 13G/A Sabby Management, Llc 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-17 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 989 7,529 13.14
2024-05-16 723 23,973 3.02
2024-05-15 19,195 69,647 27.56
2024-05-14 2,304 1,437 160.33
2024-05-13 2,418 16,730 14.45

(click for more detail)

Similar Companies
CMPX – Compass Therapeutics, Inc. CNSP – CNS Pharmaceuticals, Inc.
CNTX – Context Therapeutics Inc. COEP – Coeptis Therapeutics Holdings, Inc.
CORT – Corcept Therapeutics Incorporated


Financial data and stock pages provided by
Fintel.io